Snapshot from May 30, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / United Kingdom / Eli Lilly and Company

United Kingdom & Eli Lilly and Company

5 shared events · Importance 3 · Last updated Apr 13, 2026

Importance
3
Shared Events
5
Actions
0
Sentiment
13.333333333333334
Live sentiment trends, interaction importance charts, and action volume tracking available on the NewsDesk Dashboard
Shared Events (5)
0
Business
Eli Lilly Hikes UK Mounjaro Price
Aug 14, 2025 · 10 articles
0
Tech
OSA Linked to Higher Cardiovascular Risk
Eli Lilly and Company: Eli Lilly and Company collaborated on a new study that found a 71% higher risk of cardiovascular events or death in people with obstructive sleep apnea, especially those with obesity. This research could influence the development of new treatments and diagnostics, potentially benefiting Eli Lilly and Company's market position in related therapeutic areas.
Apr 03, 2026 · 6 articles
0
Regulatory
Trump Imposes New Pharma, Metal Tariffs
Apr 02, 2026 · 23 articles
0
International
Iran War De-escalation Hopes Boost Markets
Apr 01, 2026 · 15 articles
0
Tech
Alzheimer's Anti-Amyloid Drugs Ineffective
Eli Lilly and Company: Eli Lilly and Company produces donanemab (Kisunla), one of the anti-amyloid drugs whose effectiveness was questioned by the Cochrane review, potentially impacting its sales and stock price.
Apr 16, 2026 · 6 articles
NEWSDESK
Explore this relationship live

Track how United Kingdom and Eli Lilly and Company interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.